<i>NPRL2</i> gene therapy induces effective antitumor immunity in <i>KRAS/STK11</i> mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model. [PDF]
Meraz IM +8 more
europepmc +1 more source
A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice. [PDF]
De Angelis ML +16 more
europepmc +1 more source
Butterfly blues and greens caused by subtractive colour mixing of carotenoids and bile pigments. [PDF]
Stavenga DG.
europepmc +1 more source
Integrated metabolomics and transcriptomics reveal the potential of hydroxy-alpha-sanshool in alleviating insulin resistance. [PDF]
Zhu Y +6 more
europepmc +1 more source
A CRISPRi/a screening platform to study cellular nutrient transport in diverse microenvironments. [PDF]
Chidley C +6 more
europepmc +1 more source
Mitolnc controls cardiac BCAA metabolism and heart hypertrophy by allosteric activation of BCKDH. [PDF]
Weiss M +6 more
europepmc +1 more source
A novel USP4 inhibitor that suppresses colorectal cancer stemness by promoting β-catenin and Twist1 degradation. [PDF]
Li F +12 more
europepmc +1 more source
PAX2 induces endometrial cancer by inhibiting mitochondrial function via the CD133-AKT1 pathway. [PDF]
Hua F, Cai Y.
europepmc +1 more source
Related searches:
The mTOR/4E-BP1/eIF4E signalling pathway as source of cancer drug targets.
Current Medicinal Chemistry, 2022The mechanistic/mammalian target of rapamycin (mTOR) is the crucial hub of signalling pathways that regulate essential steps in the cell life cycle. Once incorporated in the mTORC1 complex, mTOR phosphorylates the eukaryotic initiation factor 4E (eIF4E)-
C. Maracci +5 more
semanticscholar +1 more source

